why is there a shortage of glp 1 National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and FDA says shortage of GLP-1
Description
Rare but serious effects (0.11.2%) for both agents include bone marrow suppression (neutropenia, agranulocytosis, eosinophilia, leucopenia)
The proportion of individuals with weight loss above 5% was also higher for tirzepatide (6580%) than for SMG (54%)
S., Hafermann, J
Gastro-oesophageal reflux, a known side effect of Saxenda, could theoretically contribute to throat irritation in susceptible individuals
Disclaimer: TMates is not a pharmacy or insurance company
2014 [cited 2025 Nov 12];40:16070
